Translate Bio Announces Publication of Preclinical Data Demonstrating Efficacy of Systemic mRNA...
LEXINGTON, Mass., March 18, 2019 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing...